COVID-19 Resource Center

COVID-19 Resource Center

As the pandemic enters it’s third year, the Quadax Resource Center is here to help keep you up to date on the latest COVID-19 topics, including payor and billing changes affecting reimbursement.

COVID-19 Payer Updates

Quadax is dedicated to keeping our clients up-to-date on the billing, reporting, and procedural information specific to each payer as it pertains to COVID-19.

Recent Blog Posts

2021 CAQH Report: Potential Savings Up 32% for Healthcare Transactions

Potential savings from automating common healthcare administrative transactions increased 32% due to higher costs for more complex manual transactions due to the demands of working through a national pandemic, finds the 2021 CAQH Index.

As COVID-19 forced people to work from home and practice social distancing, health plan and provider staff did not have access to office equipment and/or were closed temporarily, meaning staff relied more on the use of electronic transactions to conduct administrative transactions. Conversely, medical transaction volume was down 11% due to healthcare policies, regulations, resources and social behaviors.

COVID-19 Articles, Bulletins, Town Halls, Webinars

Date

Article

Source

6/14/2022

The FDA issued an emergency use authorization (EUA) for the Laboratory Corporation of America (Labcorp) VirSeq SARS-CoV-2 NGS Test on the PacBio Sequel II sequencing system. 

6/8/2022

COVID-19 test demand a boon for labs, a bane for costs, study finds

6/7/2022

New Current Procedural Terminology (CPT®) codes have been created that streamline the reporting of immunizations for the novel coronavirus (SARS-CoV-2, also known as COVID-19).

6/7/2022

FDA Roundup: Additional guidance to help prescribers evaluate potential drug interactions when using Paxlovid therapy for COVID-19

6/3/2022

HHS Extends American Rescue Plan Spending Deadline for States to Expand and Enhance Home- and Community-Based Services for People with Medicaid

5/26/2022

New Administration Code for Pfizer Pediatric Vaccine Booster Dose.

5/25/2022

Provider Relief Fund Reporting Requirements and Auditing

5/25/2022

What Happens to COVID Tests After Public Health Emergency Ends?

5/20/2022

Know Your Treatment Options for COVID-19 Consumer Update - Refreshed

5/17/2022

The FDA issued an Emergency Use Authorization (EUA) for the Laboratory Corporation of America (Labcorp) Pixel by Labcorp COVID-19+Flu+RSV Test Home Collection Kit for use with the Labcorp Seasonal Respiratory Virus RT-PCR DTC Test

5/17/2022

Federal government offers more free COVID-19 tests

5/16/2022

HHS to Discontinue Providing Viral Transport Media to States and Jurisdictions

5/16/2022

Hospital Groups Ask HHS to Expand COVID-19 Public Health Emergency

5/10/2022

U.S. will limit next-generation Covid vaccines to high-risk people this fall if Congress doesn’t approve more funding

5/6/2022

Rising hospitalizations put CDC's COVID-19 prevention guidelines to the test

5/5/2022

Federal funds for uninsured COVID patients dry up as hospital costs rise

5/5/2022

Labor, Medications, and Supply Costs Plague Hospitals and Health Systems

5/4/2022

How One Medicaid Program May Prevent Coverage Loss Post-COVID

5/5/2022

FDA Limits Use of Janssen COVID-19 Vaccine to Certain Individuals

5/2/2022

Loss of Pandemic Aid Stresses Hospitals That Treat The Uninsured

4/27/2022

COVID-19 Uninsured Relief Fund Joint Letter

4/26/2022

FACT SHEET: Biden Administration Increases Access to COVID-⁠19 Treatments and Boosts Patient and Provider Awareness

4/26/2022

CDC estimates 58% of Americans have been infected with SARS-CoV-2

4/26/2022

White House expands access to COVID-19 antiviral pills

4/19/2022

HHS Distributes $1.75B in Phase 4 COVID-19 Provider Relief Funds

4/14/2022

COVID-19: New Codes for Moderna Vaccine Booster Doses

4/12/2022

Renewal of De​​termination That A Public Health Emergency Exists

4/7/2022

System Limitation Update for Centralized Flu Billers (CFB), Pneumococcal and Covid-19 Vaccinations

4/6/2022

The Uninsured Program stopped accepting claims due to a lack of sufficient funds

4/6/2022

Eligible Individuals Can Receive Second COVID-19 Booster Shot at No Cost

4/4/2022

Telehealth Place of Service Code

4/4/2022

Biden-Harris Administration Announces New Way for Medicare Beneficiaries to Get Free Over-the-Counter COVID-19 Tests

4/1/2022

FDA Roundup - Revised guidance: Emergency Use Authorization for Vaccines to Prevent COVID-19

3/31/2022

Medicare Fee-for-Service Claims and the Sequestration Payment Adjustment Changes

3/31/2022

COVID-19 guidance for your community

3/31/2022

COVID pandemic’s end may bring turbulence for US health care

3/29/2022

FDA Roundup: Manufacturing change for Moderna COVID-19 Vaccine

3/29/2022

FDA Authorizes Second Booster Dose of Two COVID-19 Vaccines for Older and Immunocompromised Individuals

3/27/2022

Post-Pandemic Strategies for Labs Include OIG Audit Prep and Repurposed Instruments

3/25/2022

Free COVID-19 tests ending for uninsured Americans

3/23/2022

AHA urges Congress to provide additional COVID-19 relief

3/22/2022

COVID budget impasse halts aid to test and treat uninsured

3/22/2022

Lab Advisory: Upcoming Schedule Changes for Clinical Laboratory COVID-19 Response Calls

3/22/2022

HHS Distributing an Additional $413 Million in Provider Relief Fund Payments to Health Care Providers Impacted by the COVID-19 Pandemic

3/21/2022

Coronavirus (COVID-19) Update: FDA to Hold Advisory Committee Meeting on COVID-19 Vaccines to Discuss Future Boosters

3/21/2022

Lab Alert: FDA Recalls Specific Lot Numbers of Celltrion DiaTrust™ COVID-19 Ag Rapid Test

3/18/2022

FDA Roundup: Additional COVID-19 Test FAQs.

3/17/2022

Provider Relief Fund Reporting Period 2

3/15/2022

COVID-19 Claims Reimbursement - Uninsured Program Funds

3/11/2022

FDA Roundup 3/11/22

3/10/2022

Lab Advisory 3/10/22. HHS Updates COVID-19 Laboratory Reporting Guidance.

3/10/2022

AHA Asks CMS to Waive Medicare Advantage Prior Authorization During PHE

3/9/2022

Congress set to add 151 days of telehealth coverage

3/8/2022

Fact Sheet: Biden Administration Launches Nationwide Test-to-Treat Initiative Ensuring Rapid ‘On the Spot’ Access to Lifesaving COVID Treatments

3/8/2022

Americans can now order four more free at-home Covid-19 tests

3/4/2022

Biden extends FEMA COVID-19 funding through July 1

3/2/2022

Lab Alert: FDA Says Do Not Use These Unauthorized COVID-19 Tests

3/2/2022

New ICD-10-CM/PCS Codes, Effective April 1, 2022

3/1/2022

FDA Roundup: COVID Testing Updates

2/25/2022

FDA Roundup: COVID Testing Updates

2/24/2022

HHS Distributing $560 Million in Provider Relief Fund Payments to Health Care Providers Affected by the COVID-19 Pandemic

2/21/2022

COVID-19 CPT coding and guidance

2/18/2022

FDA Roundup: COVID Vaccines & Testing Updates

2/16/2022

COVID-19 Frequently Asked Questions (FAQs) on
Medicare Fee-for-Service (FFS) Billing

2/11/2022

Coronavirus (COVID-19) Update: FDA Authorizes New Monoclonal Antibody for Treatment of COVID-19 that Retains Activity Against Omicron Variant

2/8/2022

On Feb. 4, the FDA warned people not to use the E25Bio COVID-19 Direct Antigen Rapid Test (DART)

2/8/2022

Home Health Agency Providers May Be Reimbursed for COVID-19 Vaccine Administration

2/3/2022

Biden-Harris Administration Will Cover Free Over-the-Counter COVID-19 Tests Through Medicare

2/1/2022

AMA announces CPT update for pediatric COVID-19 vaccine candidate

1/28/2022

Lab Update: CDC Updates LOINC In Vitro Diagnostic (LIVD) Test Code Mapping Tool for SARS-CoV-2 Tests

1/25/2022

HHS Distributing $2 Billion More in Provider Relief Fund Payments to Health Care Providers Impacted by the COVID-19 Pandemic

1/24/2022

Coronavirus (COVID-19) Update: FDA Limits Use of Certain Monoclonal Antibodies to Treat COVID-19 Due to the Omicron Variant

1/21/2022

New ICD-10 Code for Post-COVID Conditions, following the 2019 Novel Coronavirus (COVID_19). 

1/20/2022

Healthcare Common Procedure Coding System (HCPCS) Codes Subject to and Excluded from Clinical Laboratory Improvement Amendments (CLIA) Edits.

1/19/2022

COVID-19 Vaccination Requirements for Health Care Providers and Suppliers - Requirement Infographic

1/14/2022

Renewal of De​​termination That A Public Health Em​ergency Exists.

1/13/2022

Lab Alert: Stop Using LuSys Laboratories COVID-19 Tests

1/10/2022

Biden-Harris Administration Requires Insurance Companies and Group Health Plans to Cover the Cost of At-Home COVID-19 Tests, Increasing Access to Free Tests

1/6/2022

COVID-19 Vaccine & Monoclonal Antibody Products: Changes for MA Plan Claims Started January 1

1/4/2022

CDC Warns of Supply Shortages as Testing Spikes in Wake of Omicron Variant

1/3/2022

Coronavirus (COVID-19) Update: FDA Takes Multiple Actions to Expand Use of Pfizer-BioNTech COVID-19 Vaccine

12/29/2021

Two New Over-the-Counter At-Home COVID-19 Tests Brought to U.S. Market Quickly by Biden-Harris

12/23/2021

Coronavirus (COVID-19) Update: December 23, 2021

12/23/2021

HHS Announces Availability of Nearly $48 Million to Increase the Public Health Workforce in Rural and Tribal Communities

12/22/2021

New Guidance to Boost Accessibility and Equity in COVID-19 Vaccine Programs

12/21/2021

Coronavirus (COVID-19) Update: December 21, 2021

12/17/2021

Coronavirus (COVID-19) Update: December 17, 2021

12/14/2021

HHS Is Releasing $9 Billion in Provider Relief Fund Payments to Support Health Care Providers Affected by the COVID-19 Pandemic

12/10/2021

The FDA updated the SARS-CoV-2 Viral Mutations: Impact on COVID-19 Tests web page to share the latest information

12/9/2021

MLN Connects: Publications - Independent Diagnostic Testing Facility (IDTF)- Revised.

12/8/2021

HHS Awards $82 Million in American Rescue Plan Funding to Expand Home Visiting Assistance for Families Affected by the COVID-19 Pandemic

12/7/2021

COVID-19 Update: Announcing the follwing actions in ongoing response effort to the pandemic.

12/3/2021

FDA Expands Authorization of Two Monoclonal Antibodies for Treatment and Post-Exposure Prevention of COVID-19 to Younger Pediatric Patients, Including Newborns

12/3/2021

Lab Alert: CDC Update on the SARS-CoV-2 Omicron Variant

12/1/2021

COVID-19 FAQs on
Medicare Fee-for-Service (FFS) Billing

11/30/2021

COVID-19 Update: The FDA is actively working to quickly address any potential impacts of the new omicron variant on the tools to fight the pandemic.

11/24/2021

COVID-19: Pfizer & Modena Booster Shots for 18 Years and Older

11/23/2021

COVID Update: Over-the-counter (OTC) COVID-19 antigen diagnostic tests

FDA

11/22/2021

Over The Counter (OTC) Home Testing and CLIA Applicability
(Frequently Asked Questions)

11/18/2021

Changes to Nursing Home Visitation COVID-19 (Revised) & COVID-19 Survey Activities

11/16/2021

The FDA took several important actions intended to support ongoing nationwide COVID-19 testing efforts.

11/15/2021

FDA Updates Test Policies to Help to Ensure Accuracy and Reliability of Tests and Increase Access to At-Home Tests

11/10/2021

HHS Announces $143.5 Million to Expand Community-Based Efforts to Address Barriers to COVID-19 Vaccination

11/4/2021

COVID-19 Vaccines for Children

11/4/2021

Biden-Harris Administration Issues Emergency Regulation Requiring COVID-19 Vaccination for Health Care Workers

11/4/2021

COVID-19 Vaccine Webinar for Rural Communities

10/27/2021

HRSA COVID-19 Claims Reimbursement to Health Care Providers/ acilities for Testing and Treatment of the Uninsured

10/26/2021

The FDA Issued an EUA for the Celltrion DiaTrust COVID-19 Ag Home Test, an OTC COVID-19 diagnostic antigen test.

10/21/2021

Lab Alert: CDC Updates LOINC In Vitro Diagnostic (LIVD) Test Code Mapping Tool for SARS-CoV-2 Tests to Include SNOMED-CT Saliva Terms

10/21/2021

CDC Expands Eligibility for COVID-19 Booster Shots

10/15/2021

HHS renews COVID-19 emergency declaration for 90 days

10/5/2021

COVID-19 Update

10/4/2021

FDA Authorizes Additional OTC Home Test to Increase Access to Rapid Testing for Consumers

10/4/2021

Lab Alert: Ellume Issues Voluntary Recall of Specific Lots of Ellume COVID-19 Home Tests

9/29/2021

New COVID-19 Vaccine Codes: September Update

9/24/2021

CMS Will Pay for COVID-19 Booster Shots, Eligible Consumers Can Receive at No Cost


9/22/2021

Lab Advisory: CDC Updates SARS-CoV-2 Variant Classifications

9/22/2021

FDA Authorizes Booster Dose of Pfizer-BioNTech COVID-19 Vaccine for Certain Populations

9/10/2021

COVID-19 Update

9/10/2021

HHS Announces the Availability of $25.5 Billion in COVID-19 Provider Funding

9/3/2021
AMA Announces Update to COVID-19 Vaccine CPT Codes

9/2/2021

Lab Advisory: Shortage of COVID-19 Rapid Tests May Increase Demand for Laboratory Testing

9/2/2021

Provider Enrollment Activities Resume in October

9/1/2021

FDA to Hold Advisory Committee Meeting to Discuss Pfizer-BioNTech’s Application for COVID-19 Booster

8/24/2021

CMS Expands Medicare Payments for At-Home COVID-19 Vaccinations

8/23/2021

FDA Approves First

COVID-19 Vaccine

8/18/2021

Joint Statement from

HHS Public Health and Medical Experts on

COVID-19 Booster Shots

8/9/2021

UPDATE: Lab Advisory 8/9/21: SARS-CoV-2 Variant Classification Updates

8/6/2021

Clinical Laboratory COVID-19 Response Call on Monday, August 23 at 3:00 PM ET

8/2/2021

Lab Alert: Clarifications about the Retirement of the CDC 2019 Novel Coronavirus (2019-nCov) Real-Time RT-PCR Diagnostic Panel

8/2/2021

Hospital Inpatient Prospective Payment System Final Rule Increases Payments to Treat COVID-19 and Improves Quality of Data Collection

7/30/2021

Coronavirus (COVID-19) Update

7/21/2021

Lab Alert: Changes to CDC RT-PCR for SARS-CoV-2 Testing

7/20/2021

Lab Advisory: SARS-CoV-2 Variant Classification Updates

7/18/2021

Lab Alert: FDA Revokes EUA for Curative SARS-CoV-2 Assay

7/15/2021

Lab Advisory: CDC Updates Pooling Guidance and Overview of Testing for SARS-CoV-2 Web Pages

7/13/2021

Revised fact sheets for the Johnson & Johnson (Janssen) COVID-19 Vaccine to include information pertaining to an observed increased risk of Guillain-Barré Syndrome (GBS) following vaccination.

7/8/2021

COVID-19 Snapshot: Impact on the Medicare Population

7/8/2021

COVID-19 Accelerated and Advance Payments: Updated FAQs. 

7/6/2021

Lab Advisory: SARS-CoV-2 Variants AY.1 and AY.2 Now Aggregated with Delta Variant B.1.617.2

6/30/2021

CDC Launches New COVID-19 Viral Testing Tool

6/29/2021

Lab Update: SARS-CoV-2 Variant Classification Changes

6/17/2021

CMS Infographic: Medicare Payment for COVID-19 Vaccination Administered in the Home

6/16/2021

CDC Updates Guidance for Reporting SARS-CoV-2 Sequencing Results.

6/15/2021

Coronavirus (COVID-19) Update

6/14/2021

Lab Alert: Sodium Citrate Blood Specimen Collection Tubes in Short Supply

6/14/2021

Lab Advisory: CDC Launches New COVID-19 Viral Testing Tool

6/10/2021

CMS increase provider payment for in-home COVID-19 vaccinations

6/9/2021

Biden Administration Continues Efforts to Increase Vaccinations by Bolstering Payments for At-Home COVID-19 Vaccinations for Medicare Beneficiaries

6/9/2021

HHS Secretary Xavier Becerra to Insurers & Providers: COVID-19 Vaccines and Testing Must be Free for Patients

5/28/2021

Lab Advisory: CDC Updates Testing Strategies for SARS-CoV-2 Web Page

5/25/2021

Coronavirus (COVID-19) Update: May 25, 2021

5/25/2021

HHS to Dedicate $4.8 Billion from American Rescue Plan to COVID-19 Testing for the Uninsured

5/21/2021

Coronavirus (COVID-19) Update: May 21, 2021

5/20/2021

Lab Advisory: CDC Updates NAATs and Self-Testing Web Pages

5/19/2021

Antibody Testing Is Not Currently Recommended to Assess Immunity After COVID-19 Vaccination: FDA Safety Communication

5/18/2021

CDC Updates Interim Guidance for Antigen Testing for SARS-CoV-2

5/5/2021

SARS-CoV-2 Variant Classifications and Definitions

5/3/2021

HHS Launches New Reimbursement Program for COVID-19 Vaccine Administration Fees not Covered by Insurance

4/26/2021

Time to Say Goodbye to Some Insurers’ Waivers for Covid Treatment Fees

4/21/2021

FDA Continues Important Steps to Ensure Quality, Safety and Effectiveness of Authorized COVID-19 Vaccines

4/20/2021

The FDA issued a pooling and serial testing amendment for many molecular diagnostic COVID-19 tests that had received an emergency use authorization (EUA) for testing individual samples.

4/16/2021

Medicare FFS Claims:
2% Payment Adjustment (Sequestration) Suspended Through December

4/15/2021

Message from HHS-OIG Leadership on the COVID-19 Vaccination Program and Provider Compliance

4/6/2021

The FDA issued an Emergency Use Authorization (EUA) to Symbiotica, Inc., for the COVID-19 Self-Collected Antibody Test System

4/2/2021

HHS Secretary Xavier Becerra Announces Expansion of COVID-19 Vaccine Program to All Community Health Centers Across the Country

4/2/2021

New web page posted: SARS-CoV-2 Viral Mutations: Impact on COVID-19 Tests for clinical laboratory staff and health care providers about the impact of viral mutations on COVID-19 molecular, antigen, and serology tests

4/1/2021

Repayment of COVID-19 Accelerated and Advance Payments Began on March 30, 2021

3/30/2021

Updated Serology EUA COVID-19 Templates Available

3/30/2021

New FDA web page - SARS-CoV-2 Viral Mutations: Impact on COVID-19 Tests - for clinical laboratory staff and health care providers about the impact of viral mutations on COVID-19 molecular tests

3/26/2021

FDA issues emergency use authorization (EUA) to the Twist Bioscience Corporation for their SARS-CoV-2 NGS Assay

3/26/2021

Lab Advisory: CDC Publishes New Web Page on Nucleic Acid Amplification Tests (NAATs)

3/22/2021

Lab Update: CMS Posts FAQ for Reporting Sequencing Results for SARS-CoV-2 Variants

3/15/2021

Medicare Payment Increase for COVID-19 Vaccine

3/13/2021

Lab Alert: FDA Issues Letter about Potential False Results with Roche cobas SARS-CoV-2 & Influenza Test

3/9/2021

Senate Passes $1.9 Trillion COVID-19 Bill; Several CAP-Backed Provisions Move Forward

3/9/2021

FDA issued an Emergency Use Authorization (EUA) to Cue Health Inc. for its over-the-counter at-home diagnostic test for COVID-19.

3/9/2021

Medicare Part B Payment for COVID-19 Vaccines and Certain Monoclonal Antibodies during the Public Health Emergency

3/5/2021

COVID-19 Update: FDA Issues Authorization for First Molecular Non-Prescription, At-Home Test

3/4/2021

COVID-19 Vaccine Administration: Insurance Coverage, MBI, & MSP

3/2/2021

Lab Advisory: FDA Issues New Guidance for Evaluating Impact of Viral Mutations on COVID-19 Tests

3/2/2021

COVID-19 Update: The agency issued an Emergency Use Authorization (EUA) to Quidel for its QuickVue At-Home COVID-19 Test for at-home use with a prescription

2/27/2021

House Approves Large COVID-19 Relief Bill; Includes $7.5 Billion for Vaccine Distribution

2/26/2021

Biden Administration Strengthens Requirements that Plans and Issuers Cover COVID-19 Diagnostic Testing Without Cost Sharing and Ensures Providers are Reimbursed for Administering COVID-19 Vaccines to Uninsured

2/26/2021

ACLA Statement on President Biden’s Actions to Close Coverage Gaps for COVID-19 Testing

2/12/2021

COVID-19 Update:  The FDA revised its guidance, Investigational COVID-19 Convalescent Plasma and associated web page, to reflect the reissued Emergency Use Authorization for COVID-19 convalescent plasma

2/11/2021

COVID-19: Revised Clinician Codes Accepted with CS Modifier

2/3/2021

COVID-19 Claims Reimbursement Program Update for the Uninsured

2/2/2021

Lab Advisory: CDC Publishes New Web Pages on Genomic Surveillance for SARS-CoV-2 Variants

1/29/2021

COVID-19 Update: The FDA has added content to the Q&A appendix in “Conduct of Clinical Trials of Medical Products During the COVID-19 Public Health Emergency"

1/28/2021

HHS Announces Marketplace Special Enrollment Period for COVID-19 Public Health Emergency

1/21/2021

ACLA Statement on President Biden's Actions to Combat COVID-19

1/19/2021

Find your COVID-19 Vaccine CPT® Codes

1/8/2021

FDA Issues Alert Regarding SARS-CoV-2 Viral Mutation to Health Care Providers and Clinical Laboratory Staff

1/8/2021

Coronavirus (COVID-19) Update: January 8, 2021

1/4/2021

New ICD-10-CM code for the
2019 Novel Coronavirus (effective 1/1/21)

12/22/2020

Coronavirus (COVID-19) Update: December 22, 2020

12/19/2020

CMS Updates FAQs for CLIA Guidance during the COVID-19 Public Health Emergency

12/15/2020

FDA Takes Key Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for First COVID-19 Vaccine

12/15/2020

FDA Authorizes Antigen Test as First Over-the-Counter Fully At-Home Diagnostic Test for COVID-19

12/11/2020

COVID-19 and in vitro diagnostics: New market forces at play

12/10/2020

CMS offers guidance in billing Medicare for COVID-19 antibody treatment

12/10/2020

FAQs–Application of OIG's Administrative Enforcement Authorities to Arrangements Directly Connected to the Coronavirus Disease 2019 (COVID-19) Public Health Emergency

12/7/2020

Lab Advisory: CMS Revises Enforcement Discretion for SARS-CoV-2 Point-of-Care Tests

12/5/2020

Lab Update: CDC Updates SARS-CoV-2 Antigen Testing Guidance

12/3/2020

Lab Update: CDC Offers New COVID-19 Specimen Collection Infographics

12/4/2020

13 insurers extending COVID-19 cost-sharing waivers into 2021

12/3/2020

COVID-19 Frequently Asked Questions (FAQs) on Medicare Fee-for-Service (FFS) Billing

12/1/2020

Job Aids for Laboratory Professionals

12/1/2020

Clinical Laboratory COVID-19 Response Calls

11/24/2020

Guidance for SARS-CoV-2 Point-of-Care Testing

11/24/2020

Pathologists Advocate for Higher COVID-19 Payments During AMA Meeting

11/24/2020

A Closer Look at COVID-19 Diagnostic Testing

11/23/2020

2020 Clinical Lab & Pathology Resources

11/19/2020

HHS Launches Pilot Program of Fast Molecular POC Test for COVID-19

11/18/2020

Virtual Town Hall Series - Coronavirus (COVID-19) Test Development and Validation

11/18/2020

The FDA issued an EUA for the first COVID-19 diagnostic test for self-testing at home that provides rapid results

11/18/2020

The FDA published a new "FDA Insight" podcast titled: "Personal Protective Equipment and COVID-19"

11/17/2020

CAP Members Call on Congress to Stop Medicare Cuts

11/17/2020

CAP Asks CMS to Reduce COVID-19 Laboratory Reporting Burdens, Increase Testing Resources

11/11/2020

CMS Details Medicare Payment for New COVID-19 Antibody Drug

11/10/2020

AMA Announces Vaccine-Specific CPT Codes for COVID-19 Immunizations

11/9/2020

The FDA issued an emergency use authorization (EUA) for the investigational monoclonal antibody therapy bamlanivimab for the treatment of mild-to-moderate COVID-19 in adult and pediatric patients

11/2/2020

Clinical Laboratories Need Creative Staffing Strategies to Keep and Attract Hard-to-Find Medical Technologists, as Demand for COVID-19 Testing Increases